Reducing the time between contracting HIV and being diagnosed and starting treatment is key to ending the epidemic, this study finds.
Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work
Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.
In this op-ed, a group of family physicians and HIV specialists revisit the cruel reality happening at the U.S. border for people living with HIV.
Even in the medical and research communities, stigmatizing language lives on, and it can have negative repercussions in the lives of people with HIV.
What Needs to Happen Before California Pharmacies Can Sell PrEP and PEP Without an Initial Prescription
Pharmacists will increasingly play a role in pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) access in California.
Oct. 24, 2019: A computerized antiretroviral recommendation tool; higher Fiebig stage equals more frequent viral load blips; low prescription refill rates among Americans starting treatment; internalized stigma and HIV outcomes.
Oct. 10, 2019: Long-term viral suppression = zero genital tract shedding among women; HIV treatment initiation and sexual risk among MSM; PrEP interest vs. uptake among trans women of color; polypharmacy among people living with HIV.
Young people in the nation's capital are living in the middle of some of the worst structural and systemic inequalities in America. We should be helping them out.
"Providers need to not make assumptions about what black and brown and, more generally, trans patients of color need," one study co-author said.
Recent Trump administration policies on migrants living with HIV have prompted a response from the international AIDS research community.